Zealthy advertises compounded semaglutide from $151/month when purchased quarterly, but the upfront total and membership fee remain undisclosed.

Zealthy advertises compounded semaglutide from $151 per month when paying quarterly upfront, but the total quarterly charge, membership fees, and month-to-month cash rate remain undisclosed on public pages.

Zealthy advertises compounded semaglutide at $151 per month when billed quarterly, but the membership fee, upfront total, and monthly billing option are not disclosed on its public pricing page—making an all-in cost comparison impossible without completing checkout.

Zealthy does not publish verified tirzepatide pricing on its public site. This review documents what is disclosed, what remains behind the intake wall, and how that compares to programs with transparent tirzepatide rates.

Zealthy does not disclose its dose-price policy on its public pricing page. Evidence shows quarterly semaglutide billing from $151 per month, but whether the company charges more as patients titrate upward is not documented.

Zealthy advertises compounded semaglutide from $151/month when purchased quarterly, but the upfront total, membership fee, and month-to-month rate remain undisclosed on public pages as of September 2026.

Zealthy advertises compounded semaglutide at $151/month when billed quarterly, but the full upfront total and membership costs remain undisclosed at the pricing page. We compare transparent monthly options and show the 12-month cost picture.

Zealthy advertises $151/month compounded semaglutide billed quarterly, but membership fees, upfront totals, and cancellation terms remain undisclosed on the public page. Here's what the evidence shows—and what you'll need to confirm at checkout.

Zealthy advertises compounded semaglutide from $151/month on a quarterly plan, plus a $135/month membership fee. Pricing was captured from public pages but not confirmed at checkout; this analysis compares advertised figures and notes where verification is incomplete.

Zealthy advertises compounded semaglutide from $151 per month on a quarterly prepaid plan, but checkout totals and membership fees are not disclosed on its public pages. PlexusDx offers transparent month-to-month and prepaid pricing with no membership fee.

Zealthy advertises compounded semaglutide at a quarterly prepaid rate, but critical details—quarterly upfront total, membership fees, and verified customer reviews—remain undisclosed in public documentation, making a complete value judgment impossible without checkout verification.

Zealthy advertises compounded semaglutide at $151/month, but this figure is a quarterly prepaid equivalent with undisclosed upfront totals and membership fees. The month-to-month rate is not published.

Zealthy advertises compounded semaglutide from $151 monthly when paid quarterly, but the upfront total and membership fees remain undisclosed on public pages. PlexusDx lists transparent month-to-month and prepaid rates with no hidden membership.

Found offers checkout-verified pricing on month-to-month and prepaid plans with insurance options; Zealthy's published figures combine medication and membership fees but were not yet checkout-verified as of July 2026.

Embody publishes verified all-in pricing at $299–$349/month with no membership fee. Zealthy advertises medication-only rates plus a $135/month membership, but we have not yet verified checkout totals. Here's what the evidence shows.

We attempted to compare Peak Wellness and Zealthy GLP-1 programs but could not verify Zealthy's pricing or terms at checkout. Here's what the available evidence shows and where it falls short.

Remedy Meds offers a verified microdose plan at $189/month all-in with unlimited clinician visits. Zealthy advertises standard-dose medication from $199/month plus a required $135/month membership. We compare structures, verify what's confirmed, and show where PlexusDx fits.

Zealthy pricing for GLP-1 medications varies by medication type and subscription tier. Understanding the full cost structure—including pharmacy fees, provider consultations, and monitoring—helps patients make informed decisions when comparing compounded GLP-1 options.

FuturHealth and Zealthy represent different approaches to GLP-1 therapy delivery and personalization.

Is Zealthy a legitimate GLP-1 telehealth operator? This independent editorial review weighs the markers that matter — clinician licensing, the 503A compounding pathway, clinical oversight, and pricing transparency — then adds the genetic layer that most telehealth reviews never mention.

A Zealthy Review examines telehealth GLP-1 access models.

Ro and Zealthy are telehealth GLP-1 platforms serving different patient needs. Ro emphasizes broad access and brand-name medications, while Zealthy focuses on clinical personalization and compounded options.

Zealthy Cost is a telehealth platform offering compounded GLP-1 medications with transparent pricing.

Zealthy Zepbound is a telehealth platform providing tirzepatide (the active ingredient in branded Zepbound) for weight management. Compounded tirzepatide and semaglutide from licensed 503A pharmacies offer cost-effective, personalized alternatives with genetic insight support.

Zealthy Legit is a telehealth platform offering GLP-1 medications for weight management. This article examines Zealthy's clinical model, safety oversight, and how it compares to evidence-based standards, helping you assess provider credibility.

Zealthy Mounjaro is a telehealth platform providing access to branded tirzepatide for weight management and metabolic health. Understanding its clinical profile, cost structure, and how it aligns with personalized genetic insights can help you make an informed decision about GLP-1 therapy options.

Zealthy and Hers offer telehealth pathways to GLP-1 medications with different clinical frameworks. Understanding how genetics and biomarkers inform treatment selection can help patients and providers make data-driven decisions aligned with individual metabolic profiles.

Zealthy and Henry Meds are telehealth platforms offering GLP-1 medications for weight management. Understanding your genetic predispositions in peptide pathways can support a more informed conversation with a provider about which platform and medication may align with your health profile.

Zealthy Price is a digital GLP-1 platform offering tiered subscription access to semaglutide and tirzepatide. Understanding the relationship between cost, clinical outcomes, and personalization can help you evaluate whether Zealthy or compounded GLP-1 alternatives align with your metabolic needs.

Zealthy Ozempic is a telehealth platform offering branded semaglutide prescriptions.